Literature DB >> 28895090

Effort and neuropsychological performance in HIV-infected individuals on stable combination antiretroviral therapy.

Robert Paul1,2, Gina Rhee3, Laurie M Baker1,2, Florin Vaida4, Sarah A Cooley3, Beau M Ances5,6.   

Abstract

The expression of cognitive symptoms associated with HIV varies over time and across individuals. This pattern may reflect transient contextual factors, including the degree of effort exerted by individuals undergoing cognitive testing. The present study examined whether effort corresponds to the expression of persistent HIV-related cognitive impairment among individuals receiving combination antiretroviral therapy (cART). HIV+ individuals (n = 111) averaged 48.2 (14.9) years of age and 13.0 (2.7) years of education and HIV- individuals (n = 92) averaged 34.9 (17.2) years of age and 13.5 (1.9) years of education. Participants completed a neuropsychological battery and a clinically validated measure of effort (Test of Memory Malingering, trial 1). Results revealed that the vast majority of HIV+ (85%) and HIV- (89%) individuals performed above published guidelines for adequate effort. Furthermore, the expression of cognitive impairment in HIV was not related to effort performance. The results were unchanged when examining HIV+ individuals with and without viral suppression. Finally, disability and disability-seeking status, and a proxy measure of apathy did not correspond to effort levels in HIV+ individuals. These findings suggest that variability in the expression of cognitive impairment in the cART era is unlikely to represent overt effort failures or other confounds unrelated to the disease. Persistent cognitive impairment in HIV likely represents historical and/or ongoing disease mechanisms despite otherwise successful treatment.

Entities:  

Keywords:  Cognition; Effort; HIV; Neuropsychological performance; Test of Memory Malingering (TOMM)

Mesh:

Year:  2017        PMID: 28895090      PMCID: PMC5656505          DOI: 10.1007/s13365-017-0557-5

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  50 in total

1.  Action verbal fluency normative data for the elderly.

Authors:  Andrea L Piatt; Julie A Fields; Anthony M Paolo; Alexander I Tröster
Journal:  Brain Lang       Date:  2004-06       Impact factor: 2.381

2.  A survey of neuropsychologists' beliefs and practices with respect to the assessment of effort.

Authors:  Michael J Sharland; Jeffrey D Gfeller
Journal:  Arch Clin Neuropsychol       Date:  2007-02-05       Impact factor: 2.813

Review 3.  Neuropathological sequelae of Human Immunodeficiency Virus and apathy: A review of neuropsychological and neuroimaging studies.

Authors:  Roger C McIntosh; Monica Rosselli; Lucina Q Uddin; Michael Antoni
Journal:  Neurosci Biobehav Rev       Date:  2015-05-02       Impact factor: 8.989

Review 4.  Mental disorders and drug abuse in persons living with HIV/AIDS.

Authors:  W D Klinkenberg; S Sacks
Journal:  AIDS Care       Date:  2004

5.  Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders.

Authors:  Andrew J Levine; Eileen Martin; Ned Sacktor; Cynthia Munro; James Becker
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

6.  The effect of distraction on the Word Memory Test and Test of Memory Malingering performance in patients with a severe brain injury.

Authors:  Kellie Batt; E Arthur Shores; Eugene Chekaluk
Journal:  J Int Neuropsychol Soc       Date:  2008-11       Impact factor: 2.892

7.  On the limits of effort testing: symptom validity tests and severity of neurocognitive symptoms in nonlitigant patients.

Authors:  Thomas Merten; Linda Bossink; Ben Schmand
Journal:  J Clin Exp Neuropsychol       Date:  2007-04       Impact factor: 2.475

8.  Prevalence of cognitive impairment in systemic lupus erythematosus.

Authors:  R M Carbotte; S D Denburg; J A Denburg
Journal:  J Nerv Ment Dis       Date:  1986-06       Impact factor: 2.254

9.  HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.

Authors:  J Allen McCutchan; Julia W Wu; Kevin Robertson; Susan L Koletar; Ronald J Ellis; Susan Cohn; Michael Taylor; Steven Woods; Robert Heaton; Judith Currier; Paige L Williams
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

Review 10.  Controversies in HIV-associated neurocognitive disorders.

Authors:  Sam Nightingale; Alan Winston; Scott Letendre; Benedict D Michael; Justin C McArthur; Saye Khoo; Tom Solomon
Journal:  Lancet Neurol       Date:  2014-11       Impact factor: 44.182

View more
  8 in total

1.  Intraindividual variability in neurocognitive performance: No influence due to HIV status or self-reported effort.

Authors:  Andrew J Levine; Eileen Martin; Cynthia A Munro; Ned Sacktor; Steve Horvath; James T Becker
Journal:  J Clin Exp Neuropsychol       Date:  2018-08-20       Impact factor: 2.475

2.  Cognitive Phenotypes of HIV Defined Using a Novel Data-driven Approach.

Authors:  Robert H Paul; Kyu Cho; Andrew Belden; Adam W Carrico; Eileen Martin; Jacob Bolzenius; Patrick Luckett; Sarah A Cooley; Julie Mannarino; Jodi M Gilman; Mariah Miano; Beau M Ances
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-04       Impact factor: 4.147

3.  Cardiorespiratory Fitness Is Associated With Better White Matter Integrity in Persons Living With HIV.

Authors:  Collin B Kilgore; Jeremy F Strain; Brittany Nelson; Sarah A Cooley; Alexander Rosenow; Michelle Glans; William Todd Cade; Dominic N Reeds; Robert H Paul; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2022-04-15       Impact factor: 3.771

4.  Deep Learning Analysis of Cerebral Blood Flow to Identify Cognitive Impairment and Frailty in Persons Living With HIV.

Authors:  Patrick Luckett; Robert H Paul; Jaimie Navid; Sarah A Cooley; Julie K Wisch; Anna H Boerwinkle; Dimitre Tomov; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-15       Impact factor: 3.731

5.  Relationships Between Viral Load, Neuroimaging, and NP in Persons Living With HIV.

Authors:  Sarah A Cooley; Jaimie Navid; Julie K Wisch; Anna Boerwinkle; John Doyle; Robert H Paul; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2021-07-01       Impact factor: 3.771

6.  Effects of anticholinergic medication use on brain integrity in persons living with HIV and persons without HIV.

Authors:  Sarah A Cooley; Robert H Paul; Jeremy F Strain; Anna Boerwinkle; Collin Kilgore; Beau M Ances
Journal:  AIDS       Date:  2021-03-01       Impact factor: 4.632

7.  Effects of Framingham 10-Year Cardiovascular Risk Score and Viral Load on Brain Integrity in Persons With HIV.

Authors:  Michelle Glans; Sarah A Cooley; Florin Vaida; Anna Boerwinkle; Dimitre Tomov; Kalen J Petersen; Alexander Rosenow; Robert H Paul; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2022-05-01       Impact factor: 3.771

8.  Comparison of [11C]-PBR28 Binding Between Persons Living With HIV and HIV-Uninfected Individuals.

Authors:  Anna H Boerwinkle; Jeremy F Strain; Tricia Burdo; John Doyle; Jon Christensen; Yi Su; Julie K Wisch; Sarah A Cooley; Florin Vaida; Mandy D Smith; Hussain Jafri; Robert H Paul; Tammie L S Benzinger; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2020-10-01       Impact factor: 3.771

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.